NCT01951586 2021-10-25
Denosumab in Combination With Chemotherapy as First-line Treatment of Metastatic Non-small Cell Lung Cancer
Amgen
Phase 2 Completed
Amgen
Novartis
University of Alabama at Birmingham
Novartis
Sun Yat-sen University
Novartis
Novartis